PROTAGONIST THERAPEUTICS INC's ticker is PTGX and the CUSIP is 74366E102. A total of 145 filers reported holding PROTAGONIST THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.11 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $932,175 | -69.6% | 33,750 | -74.7% | 0.35% | -63.0% |
| Q1 2023 | $3,069,396 | +41.0% | 133,452 | -33.1% | 0.94% | +6.1% |
| Q4 2022 | $2,177,000 | +29.4% | 199,500 | 0.0% | 0.88% | +90.7% |
| Q3 2022 | $1,682,000 | +37.2% | 199,500 | +28.7% | 0.46% | -8.0% |
| Q2 2022 | $1,226,000 | -93.3% | 155,000 | -79.9% | 0.50% | -92.9% |
| Q1 2022 | $18,216,000 | +69.7% | 769,250 | +145.0% | 7.12% | +68.3% |
| Q4 2021 | $10,736,000 | -30.0% | 313,929 | -8.1% | 4.23% | -15.8% |
| Q2 2021 | $15,333,000 | +130.3% | 341,650 | +32.9% | 5.02% | +203.9% |
| Q1 2021 | $6,659,000 | +27.4% | 257,086 | -0.8% | 1.65% | -13.0% |
| Q4 2020 | $5,227,000 | – | 259,283 | – | 1.90% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JOHNSON & JOHNSON | 2,449,183 | $43,400,000 | 3.81% |
| BVF INC/IL | 3,901,759 | $69,139,000 | 2.70% |
| COMMODORE CAPITAL LP | 498,079 | $8,826,000 | 2.33% |
| Altium Capital Management LP | 346,000 | $6,131,000 | 1.61% |
| Twin Lakes Capital Management, LLC | 139,287 | $2,468,000 | 1.45% |
| Opaleye Management Inc. | 330,222 | $5,852,000 | 1.09% |
| EcoR1 Capital, LLC | 1,443,800 | $25,584,000 | 0.89% |
| OBERMEYER WOOD INVESTMENT COUNSEL, LLLP | 776,689 | $13,763,000 | 0.76% |
| JABODON PT CO | 90,656 | $1,606,000 | 0.66% |
| Artal Group S.A. | 1,500,000 | $26,580,000 | 0.60% |